Five years of exemestane as initial therapy compared to 5 years of tamoxifen followed by exemestane: The TEAM trial, a prospective, randomized, phase III trial in postmenopausal women with hormone-sensitive early breast cancer. - Rea,D.; Hasenburg,A.; Seynaeve,C. (Cancer Res, 2009)